Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia.

Substance use disorder was associated with non-adherence to follow up in a cohort of FES patients treated with flupenthixol decanoate. Interventions that take into account age, education and baseline positive symptoms may afford the opportunity to influence adherence and patient outcome.